Oxaliplatin Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Oxaliplatin Manufacturers of Oxaliplatin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Oxaliplatin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 85 mg/sq. metre160 (156)As recommended.IVEvery 2 weeks130 mg/sq. metre240 (238)As recommended.IVEvery 3 weeks Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Oxaliplatin is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Oxaliplatin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Oxaliplatin Back to top Manufacturers of Oxaliplatin in Pakistan A.J.Mirza Atco Aventis Bio Pharma CCL Ferozson ONCOGENE Pharmedic Pharmevo Back to top Previous Drug Generic - Next Drug Generic
Oxaliplatin Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Oxaliplatin Manufacturers of Oxaliplatin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Oxaliplatin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 85 mg/sq. metre160 (156)As recommended.IVEvery 2 weeks130 mg/sq. metre240 (238)As recommended.IVEvery 3 weeks Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Oxaliplatin is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Oxaliplatin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Oxaliplatin Back to top Manufacturers of Oxaliplatin in Pakistan A.J.Mirza Atco Aventis Bio Pharma CCL Ferozson ONCOGENE Pharmedic Pharmevo Back to top Previous Drug Generic - Next Drug Generic